Catalyst Funds Management Pty LTD Vera Therapeutics, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 1,200 shares of VERA stock, worth $59,316. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,200Holding current value
$59,316% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
181Shares Held
55.1MCall Options Held
101KPut Options Held
110K-
Avoro Capital Advisors LLC New York, NY4.31MShares$213 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$195 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$165 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$146 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$138 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.34B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...